IndraLab

Statements

Bortezomib decreases the amount of BCL2. 30 / 30
1 12 | 17
bel
"From table 1 of full text: bortezomib suppressed constitutive NF-kappaB activation via I-kappaB stabilisation in three ATL cell lines (TaY, MT-2 and MT-4). An oligonucleotide DNA microarray analysis of TaY cells revealed upregulation of genes encoding heat shock proteins (HSPA1A, STIP1, HSPA1B, and HSPCA), genes related to protein folding (CDC37 and ANAPC5), Fas-associated factor 1(FAF1) and an oxidative stress-related gene, heme oxygenase-1(HMOX-1), known to be a target gene of hypoxia-inducible gene-1 alpha (HIF-1 alpha)."
17895889
reach
"Western blot analysis demonstrated that bortezomib treatment significantly decreased the expression levels of Bcl-2 (XREF_FIG) and LC3-II (XREF_FIG), and increased the expression levels of p62, cleaved PARP and cleaved caspase-3 (XREF_FIG) in shBeclin-1 NB4 cells compared with in shCTRL cells."
33376542
ctd
No evidence text available
24377552
ctd
No evidence text available
15781649
ctd
No evidence text available
20383943
ctd
No evidence text available
17351739
ctd
No evidence text available
18928586
ctd
No evidence text available
21302442
reach
"MSC-exo inhibits the reduction of Bcl-2 expression caused by bortezomib and reduces the cleavage of caspase-9, caspase-3, and PARP."
33294586
reach
"In this model, in cells expressing p50 NFkappaB, the Bcl-2 promoter would be occupied predominantly by p50/50 homodimers, which would not regulate Bcl-2 transcription, and thus Bcl-2 expression would not be suppressed by the bortezomib induced nuclear IkappaBalpha."
21224428
reach
"Bortezomib induced apoptosis was further demonstrated by increased levels of cleaved caspase-3, cleaved PARP and Bax, and decreased expression levels of Bcl-2 (XREF_FIG and XREF_SUPPLEMENTARY)."
33376542
ctd
No evidence text available
16022909
reach
"Bortezomib slightly decreased Bcl-2 expression, but increased the expression and cleavage of Mcl-1 (XREF_FIG), which was abolished by the caspase inhibitors, Z-VAD, Z-IETD and Z-LEHD (XREF_FIG)."
27450810
reach
"PS-341 downregulated the expression of Bcl-2 and Bcl-xl in protein levels at an early time of treatment."
15531918
reach
"Conversely, in cells that do not express p50 NFkappaB, the Bcl-2 promoter might be occupied by other NFkappaB dimers, which regulate Bcl-2 transcription, and thus in these cells, Bcl-2 transcription would be inhibited by bortezomib."
21224428
reach
"Furthermore, the 26S proteasome inhibitor bortezomib can downregulate Bcl-2 expression."
18594829
ctd
No evidence text available
15131062
ctd
No evidence text available
20471514
reach
"Bortezomib targets pathways relevant to tumor progression and therapy resistance and can directly modulate expression of cyclins, p27kip1, p53, nuclear factor-kB, Bcl-2, and Bax."
15638966
ctd
No evidence text available
16446371
reach
"Bortezomib treatment in the knockdown cells increased the levels of cleaved caspase-3 and cleaved PARP, and decreased the expression levels of Bcl-2, indicating that autophagy inhibition in combination with proteasome suppression resulted in increased apoptosis."
33376542
ctd
No evidence text available
17156654
reach
"Bortezomib treatment decreased BCL2 and MCL1 levels in a dose dependent manner in both D1-GFP- and GFP expressing clones, but this effect was stronger in cyclin D1 expressing cells."
25881299
reach
"Bortezomib has been shown to reduce Bcl-2 levels and induce apoptosis in the H526 SCLC cell line [XREF_BIBR]."
25612802
reach
"The results showed that 11.55 nM HHT or 1.12 nM Bortezomib significantly increased cleavage activation of caspase 9 and caspase 3, inhibited anti-apoptotic protein Bcl-2 expression and upregulated pro apoptotic protein Bax."
26544558
ctd
No evidence text available
17327374
reach
"PS-341 not only inhibited nuclear localization of NF-kappaB but also activated the caspase cascade, increased p21 and Bax levels, and decreased Bcl-2 levels."
15131062
reach
"Bortezomib arrested the cell cycles of three cell lines at the G2/M stage, decreased BCL2 mRNA expression, but did not affect MDR1 mRNA levels."
22145750
reach
"Preclinical studies demonstrated that bortezomib reduced Bcl-2 levels and induced apoptosis in small cell lung cancer cell lines."
22205203
reach
"The addition of bortezomib to docetaxel maintains p27 induction and decreases levels of Bcl-2, enhancing docetaxel cytotoxicity."
21273177